| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.06 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |